Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - REVENUE
Revenue SPRO - Spero Therapeutics, Inc.
96.7 M
LAST VALUE
130.19%
2 YEAR CAGR
89.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR